Monthly Archives: April 2011

Emerging Markets: Looking Beyond the Heady Growth Numbers

A sweet helping of “Turkish delight” for local generic producers amounts to harsh medicine for foreign innovator firms… Emerging markets remain the ace in the card deck for big pharma seeking alternatives to the global slowdown in demand for medicines.  The “pharmerging 17” are dealing a strong hand, with a consensus for continued double-digit growth […]
Posted in Emerging Markets, Europe, Global, R&D | Tagged , , , | Leave a comment

AstraZeneca Signs Exclusive Distribution Deal for Vandetanib

As the number of drugs targeting small populations increases, managing numerous drug distribution channels and educating the relevant parties – specialty pharmacists, payers, physicians, and patients – becomes a daunting task. Specialty pharmacies that handle seven to 10 major disease states, after all, might only see three or four patients with a given rare disease, […]
Posted in Deals, FDA, healthcare, Legal, Market Access, pricing, Regulatory, Strategy | Tagged , , , | Leave a comment

A Blueprint for FDA Reform

The FDA five-year strategy emphasizes a more coordinated—and skeptical—response to globalization of the drug supply chain. On balance, the strategy continues to focus more on managing risk than assessing benefit—industry take heed. Earlier this month, FDA released a five-year, forward-looking strategic priorities report—“Responding to the Public Health Challenges of the 21st Century”—that outlines what the […]
Posted in FDA, Global | Tagged , , , , | 1 Comment

More States Follow Washington's Value-Based Lead

Cameron McClearn looks at how Washington State’s approach to health care value is beginning to influence the rest of the country. Many trends start on the West Coast and migrate to the rest of the nation. The Washington State health care system is worth watching as officials evaluate the economic value of medical treatments for […]
Posted in healthcare, pricing | Tagged , , , , , , | 2 Comments

Pharma Feels Delayed Effects of Economic Crisis

A new study from the IMS institute for Healthcare Informatics reveals that the spending increase on prescription medication in 2010 was the second-lowest increase in more than half a century. According to the IMS Institute for Healthcare Informatics, spending on prescription medications increased 2.3 percent in 2010 — a lower increase than the 5.1 percent […]
Posted in healthcare | Tagged , , | Leave a comment
  • Categories

  • Meta